Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Takimoto

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Japanese Heart Journal|September 1, 1980
Effects of experimental chronic volume overloading on left ventricular contractility and complianceK Kodama, H Morishita, T Sakurai, et al.
The European Journal of Neuroscience|September 30, 1998
Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant miceK Watase, K Hashimoto, M Kano, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|August 1, 1979
[An experimental study on pulmonary shunt during veno-venous perfusion (author's transl)]Y Yamaoka, O Nishimura, T Sakurai, et al.
Science (New York, N.Y.)|June 13, 1997
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1K Tanaka, K Watase, T Manabe, et al.
British Journal of Cancer|June 28, 2002
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokersM Takimoto, G Wei, H Dosaka-Akita, et al.
British Journal of Cancer|January 13, 2006
BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasiasK Konishi, M Takimoto, K Kaneko, et al.
Anticancer Research|August 15, 1998
Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbateH Sakagami, M Hosaka, H Arakawa, et al.
Annals of Hematology|July 10, 2019
Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II studyR Sakai, K Ohmachi, F Sano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupRamesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Japanese Heart Journal|September 1, 1980
Effects of experimental chronic volume overloading on left ventricular contractility and complianceK Kodama, H Morishita, T Sakurai, et al.
The European Journal of Neuroscience|September 30, 1998
Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant miceK Watase, K Hashimoto, M Kano, et al.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|August 1, 1979
[An experimental study on pulmonary shunt during veno-venous perfusion (author's transl)]Y Yamaoka, O Nishimura, T Sakurai, et al.
Science (New York, N.Y.)|June 13, 1997
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1K Tanaka, K Watase, T Manabe, et al.
British Journal of Cancer|June 28, 2002
Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancers of smokersM Takimoto, G Wei, H Dosaka-Akita, et al.
British Journal of Cancer|January 13, 2006
BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasiasK Konishi, M Takimoto, K Kaneko, et al.
Anticancer Research|August 15, 1998
Role of hydrogen peroxide in antitumor activity induction by sodium 5,6-benzylidene-L-ascorbateH Sakagami, M Hosaka, H Arakawa, et al.
Annals of Hematology|July 10, 2019
Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II studyR Sakai, K Ohmachi, F Sano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working GroupRamesh K Ramanathan, Merrill J Egorin, Chris H M Takimoto, et al.
Molecular Cancer Therapeutics|July 23, 2013
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasRyan T Anderson, Stephen B Keysar, Daniel W Bowles, et al.
Pageof 18